Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Oct;17 Suppl 2(0 2):S118-27.
doi: 10.1007/s10461-013-0506-0.

Contribution of substance use disorders on HIV treatment outcomes and antiretroviral medication adherence among HIV-infected persons entering jail

Affiliations

Contribution of substance use disorders on HIV treatment outcomes and antiretroviral medication adherence among HIV-infected persons entering jail

Ehsan Chitsaz et al. AIDS Behav. 2013 Oct.

Abstract

HIV and substance use are inextricably intertwined. One-sixth of people living with HIV/AIDS (PLWHA) transition through the correctional system annually. There is paucity of evidence on the impact of substance use disorders on HIV treatment engagement among jail detainees. We examined correlates of HIV treatment in the largest sample of PLWHA transitioning through jail in 10 US sites from 2007 to 2011. Cocaine, alcohol, cannabis, and heroin were the most commonly used substances. Drug use severity was negatively and independently correlated with three outcomes just before incarceration: (1) having an HIV care provider (AOR = 0.28; 95 % CI 0.09-0.89); (2) being prescribed antiretroviral therapy (AOR = 0.12; 95 % CI 0.04-0.35) and (3) high levels (>95 %) of antiretroviral medication adherence (AOR = 0.18; 95 % CI 0.05-0.62). Demographic, medical and psychiatric comorbidity, and social factors also contributed to poor outcomes. Evidence-based drug treatments that include multi-faceted interventions, including medication-assisted therapies, are urgently needed to effectively engage this vulnerable population.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Conceptual model of health behaviors among the HIV-infected persons during the pre-incarceration period – adapted from Chen N, et al. 2011 with permission.
Figure 2
Figure 2
Comparison of HIV Treatment Outcomes Among HIV-infected Drug Users Entering Jail (N=1166)

References

    1. Springer SA, Altice FL. In: Improving the Care for HIV-Infected Prisoners: An Integrated Prison-Release Health Model Public Health Behind Bars. Greifinger RB, editor. New York: Springer; 2007. pp. 535–555.
    1. Altice FL, Kamarulzaman A, Soriano VV, Schechter M, Friedland GH. Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs. Lancet. 2010 Jul 31;376(9738):367–387. - PMC - PubMed
    1. Spaulding AC, Seals RM, Page MJ, Brzozowski AK, Rhodes W, Hammett TM. HIV/AIDS among inmates of and releasees from US correctional facilities2006: declining share of epidemic but persistent public health opportunity. PLoS One. 2009;4(11):e7558. - PMC - PubMed
    1. Flanigan TP, Zaller N, Beckwith CG, et al. Testing for HIV, sexually transmitted infections, and viral hepatitis in jails: still a missed opportunity for public health and HIV prevention. J Acquir Immune Defic Syndr. 2010 Dec;55(Suppl 2):S78–S83. - PubMed
    1. Bruce RD, Smith-Rohrberg D, Altice FL. In: Pharmacological Treatment of Substance Abuse in Correctional Facilities: Prospects and Barriers to Expanding Access to Evidence-Based Therapy Public Health Behind Bars. Greifinger RB, editor. New York: Springer; 2007. pp. 385–411.

Publication types

MeSH terms

Substances